Interstitial lung diseases induced by anticancer agents (ILD-AA) are rare adverse effects of anticancer therapy. However, prognostic biomarkers for ILD-AA have not been identified in patients with advanced lung cancer. | Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer A case control study